Astonea Labs (ASTONEALAB) Share Price near 52-week high as stock trades at Rs 410
- November 18, 2026
- Posted by: Chaitanya Auti
- Category: News
Astonea Labs Share Price is trading at Rs 410, down 0.85% today, and remains near its 52-week high while the company carries a market capitalisation of Rs 404.67 crore. The latest Univest data confirms a near one-year high event in Astonea Labs Share Price, but it does not establish a company-specific catalyst. The move keeps Astonea Labs Share Price in focus for readers searching for Astonea Labs Share Price Today, Astonea Labs Stock News and Astonea Labs Share News. In the absence of a stated trigger, the useful questions are simple: what does the price action show, how do the valuation ratios compare with healthcare peers, and what should investors monitor next in Astonea Labs Share Price? Astonea Labs Share Price today also sits within a broader stock news context for the Indian stock market.
Astonea Labs Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 410 |
| Previous Close | Rs 413.5 |
| Today's Move | Rs -3.5 (-0.85%) |
| Open | Rs 410 |
| High | Rs 410 |
| Low | Rs 410 |
| Market Capitalisation | Rs 404.67 crore |
Astonea Labs Ltd. (ASTONEALAB) traded at Rs 410 versus the previous close of Rs 413.5, a fall of 0.85%. The stock opened at Rs 410, reached a high of Rs 410 and touched a low of Rs 410.
Astonea Labs Share Price opened at Rs 410, traded at Rs 410 and moved in a tight range between Rs 410 and Rs 410, while the previous close stood at Rs 413.5. The day change is Rs -3.5 and the day move is -0.85%, so Astonea Labs Share Price is slightly below the prior session’s reference level. Because the stock is trading close to its 52-week high, the near yearly high event remains the main market news point for Astonea Labs Share Price Today. For readers tracking Astonea Labs Stock News, the important fact is straightforward: the share price is holding near its annual peak band, and the latest Univest figures confirm the event without assigning a cause. That keeps Astonea Labs Share Price News relevant for near-term watchers of price behaviour and market updates.
Astonea Labs Ltd. (ASTONEALAB) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 404.67 crore |
| P/E Ratio | 96.26x |
| P/B Ratio | 7.61x |
| ROE | 11.95% |
| ROCE | 10.51% |
| EPS | Rs 4.3 |
| Book Value Per Share | Rs 54.35 |
| Dividend Yield | 0% |
Astonea Labs Ltd. (ASTONEALAB) fundamental metrics show P/E 96.26x, P/B 7.61x, ROE 11.95%, ROCE 10.51%. These figures provide context only and are not a buy or sell signal.
Astonea Labs Ltd. has a market capitalisation of Rs 404.67 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 96.26x, P/B at 7.61x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 11.95% and ROCE of 10.51%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 4.3, book value per share of Rs 54.35, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 26.36x, median ROE of 11.22%, median ROCE of 13.1%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 96.26x |
| Benchmark Median P/E | 26.36x |
| Benchmark Average P/E | 50.25x |
| Benchmark P/E Range | 0x to 1,425.63x |
| Company P/B Ratio | 7.61x |
| Benchmark Median P/B | 2.73x |
| Company ROE | 11.95% |
| Benchmark Median ROE | 11.22% |
| Company ROCE | 10.51% |
| Benchmark Median ROCE | 13.1% |
| Company Market Capitalisation | Rs 404.67 crore |
| Benchmark Median Market Cap | Rs 791.38 crore |
Astonea Labs Ltd. (ASTONEALAB) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Astonea Labs Ltd. (ASTONEALAB) has a P/E ratio of 96.26x, which is above the benchmark median of 26.36x, a difference of +265.17%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Astonea Labs Ltd. (ASTONEALAB) has a ROE of 11.95%, which is above the benchmark median of 11.22%, a difference of +6.51%. Astonea Labs Ltd. (ASTONEALAB) has a ROCE of 10.51%, which is below the benchmark median of 13.1%, a difference of -19.77%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Jenburkt Pharmaceuticals Ltd. | JENBURPH | 406.84 | 12.38 | 1.99 | 18.84 | 25.34 |
| Medicamen Biotech Ltd. | MEDICAMEQ | 414.78 | 35.71 | 1.37 | 4.23 | 6 |
| Albert David Ltd. | ALBERTDAVD | 439.45 | 15.29 | 1.04 | -0.38 | 0.83 |
| SMS Lifesciences India Ltd. | HALEOSLABS | 499.11 | 37.89 | 2.24 | 8.68 | 10.53 |
| Trident Lifeline Ltd. | TLL | 505.6 | 25.17 | 4.44 | 24.83 | 22.71 |
Astonea Labs Ltd. (ASTONEALAB) has a P/E ratio of 96.26x compared with the displayed peer median of 25.17x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 11.95% compares with a peer median of 8.68% across the companies shown in the table. ROCE stood at 10.51% versus the displayed peer median of 10.53%, providing a capital-efficiency comparison. Astonea Labs Ltd. (ASTONEALAB) has a market capitalisation of Rs 404.67 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Astonea Labs
- Astonea Labs Share Price is trading at Rs 410, near its 52-week high and one-year high.
- The day move in Astonea Labs Share Price is -0.85% versus the previous close of Rs 413.5.
- Astonea Labs Share Price has a market capitalisation of Rs 404.67 crore.
- Astonea Labs Share Price shows a P/E of 96.26 and a P/B of 7.61.
- Astonea Labs Share Price has ROE of 11.95% and ROCE of 10.51%.
About Astonea Labs
Astonea Labs Ltd. operates in the healthcare sector and the pharmaceuticals & drugs industry. For Astonea Labs Share Price readers, that classification is the most reliable company context in this article. The stock is identified on NSE and BSE, and the current market-cap profile places it within a closely followed group of listed pharmaceutical names. Astonea Labs Stock News coverage is therefore best read through the lens of price action, valuation and industry comparison rather than through unsupported business claims. For investors searching Astonea Labs Latest News or Astonea Labs Company News, the key factual anchors are the company name, segment classification, market capitalisation and the near 52-week high event in Astonea Labs Share Price.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.
Frequently Asked Questions
Why is Astonea Labs Share Price in focus today?
Ans. Astonea Labs Share Price is in focus because it is trading at Rs 410, near its 52-week high. The move is notable for readers tracking Astonea Labs Share Price Today, stock news and market-cap context.
What is Astonea Labs Share Price today?
Ans. Astonea Labs Share Price is Rs 410. It is down 0.85% from the previous close of Rs 413.5, and the stock is still positioned near its one-year high zone.
How close is Astonea Labs Share Price to its 52-week high?
Ans. Astonea Labs Share Price is trading near its 52-week high, with the current price at Rs 410. The article does not state a new record; it highlights a near-peak event only.
What is the market capitalisation of Astonea Labs?
Ans. Astonea Labs has a market capitalisation of Rs 404.67 crore. That figure helps place Astonea Labs Share Price within a smaller listed healthcare company context and compare it with peers.
What do Astonea Labs P/E and P/B show?
Ans. Astonea Labs Share Price is associated with a P/E of 96.26 and a P/B of 7.61. Both are well above the same-industry median values shown in the sector context section.
How do ROE and ROCE look for Astonea Labs?
Ans. Astonea Labs reports ROE of 11.95% and ROCE of 10.51%. Those figures give Astonea Labs Share Price a profitability and capital-efficiency context, even though the company’s ROCE is below the industry median.
How does Astonea Labs compare with healthcare peers?
Ans. Astonea Labs Share Price sits near peers with similar market capitalisation, but its P/E and P/B are higher than several listed comparables. The peer set also shows mixed ROE and ROCE readings.
What is Astonea Labs EPS and book value?
Ans. Astonea Labs has EPS of Rs 4.3 and book value per share of Rs 54.35. Those numbers help readers assess Astonea Labs Share Price against earnings per share and accounting net worth.
Track Astonea Labs Share Price on Univest
Use Astonea Labs Ltd. (ASTONEALAB) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Track Astonea Labs Share Price on Univest for live price updates, market cap, 52-week levels, valuation ratios, EPS, book value, ROE, ROCE and broader stock analysis. Univest also helps readers follow Astonea Labs Share Price Today alongside healthcare sector context, peer comparison and company news. If you are monitoring Astonea Labs Share News or Astonea Labs Stock News, Univest keeps the key metrics together in one place.